Literature DB >> 8573216

In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain.

C Cavadas1, I Araújo, M D Cotrim, T Amaral, A P Cunha, T Macedo, C F Ribeiro.   

Abstract

This work studied in vitro the interaction of aqueous and hydroalcoholic extracts of Valeriana officinalis L. and compounds that are present in the extracts (amino acids and valerenic acid) with the GABAA (gamma-aminobutyric acid) receptor, using the [3H] muscimol binding technique to crude synaptic membranes from rat brain cortices. Both extracts displaced [3H]muscimol bound and this effect is probably due only to their amino acid content, specially GABA. This fact explains the in vitro effect of valerian extracts on GABAA receptor but not their sedative effect.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8573216

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


  12 in total

Review 1.  The globalization of traditional medicine in northern peru: from shamanism to molecules.

Authors:  Rainer W Bussmann
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-28       Impact factor: 2.629

2.  Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release.

Authors:  J G Ortiz; J Nieves-Natal; P Chavez
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

3.  Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats.

Authors:  Romaiana Picada Pereira; Roselei Fachinetto; Alessandro de Souza Prestes; Caroline Wagner; Jéssie Haigert Sudati; Aline Augusti Boligon; Margareth Linde Athayde; Vera Maria Morsch; João Batista Teixeira Rocha
Journal:  J Neural Transm (Vienna)       Date:  2011-04-08       Impact factor: 3.575

4.  Neuroprotective properties of Valeriana officinalis extracts.

Authors:  João O Malva; Sandra Santos; Tice Macedo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

5.  Aqueous and Ethanolic Valeriana officinalis Extracts Change the Binding of Ligands to Glutamate Receptors.

Authors:  Lisa M Del Valle-Mojica; José M Cordero-Hernández; Giselle González-Medina; Igmeris Ramos-Vélez; Nairimer Berríos-Cartagena; Bianca A Torres-Hernández; José G Ortíz
Journal:  Evid Based Complement Alternat Med       Date:  2010-12-02       Impact factor: 2.629

6.  A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia.

Authors:  Diana M Taibi; Michael V Vitiello; Suzanne Barsness; Gary W Elmer; Gail D Anderson; Carol A Landis
Journal:  Sleep Med       Date:  2008-05-14       Impact factor: 3.492

7.  Anxiolytic actions of Nardostachys jatamansi via GABA benzodiazepine channel complex mechanism and its biodistribution studies.

Authors:  Sakina Razack; Hemanth Kumar Kandikattu; M P Venuprasad; Narayanappa Amruta; Farhath Khanum; Krishna Chuttani; Anil Kumar Mishra
Journal:  Metab Brain Dis       Date:  2018-06-22       Impact factor: 3.584

8.  Selective Interactions of Valeriana officinalis Extracts and Valerenic Acid with [H]Glutamate Binding to Rat Synaptic Membranes.

Authors:  Lisa M Del Valle-Mojica; Yoshira M Ayala-Marín; Carmen M Ortiz-Sanchez; Bianca A Torres-Hernández; Safa Abdalla-Mukhaimer; José G Ortiz
Journal:  Evid Based Complement Alternat Med       Date:  2011-04-26       Impact factor: 2.629

9.  Chemical composition and anxiolytic evaluation of Achillea Wilhelmsii C. Koch essential oil in rat.

Authors:  M B Majnooni; A Mohammadi-Farani; M B Gholivand; M R Nikbakht; G R Bahrami
Journal:  Res Pharm Sci       Date:  2013-10

10.  Evaluation of the anxiolytic effect of Nepeta persica Boiss. in mice.

Authors:  M Rabbani; S E Sajjadi; A Mohammadi
Journal:  Evid Based Complement Alternat Med       Date:  2008-06       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.